Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 1.571.551.401.552.78

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 1.57 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55
Mar20202.78

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55
-44.24
Mar2020 2.78 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹25,907.5 Cr 5.6% 2.3% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.7% -3.8% -7.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

5.6%

2.3%

-0.6%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses